Differential response of TIMP-3 null mice to the lung insults of sepsis, mechanical ventilation, and hyperoxia

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 289, Issue 2 33-2, 2005, Pages

  Martin, Erica L ^a,b   McCaig, Lynda A ^a   Moyer, Brent Z ^a   Pape, M Cynthia ^a   Leco, Kevin J ^a   Lewis, James F ^a   Veldhuizen, Ruud A W ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Compliance; Cytokines; Inflammation; Lipopolysaccharide; Matrix metalloproteinases; Tissue inhibitor of metalloproteinases

Indexed keywords

CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GELATINASE A; GELATINASE B; INTERLEUKIN 6; MATRILYSIN; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPEROXIA; INFLAMMATION; LUNG COMPLIANCE; LUNG DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS;

ANIMALS; HYPEROXIA; LIPOPOLYSACCHARIDES; LUNG COMPLIANCE; LUNG DISEASES; MATRIX METALLOPROTEINASES; MICE; MICE, KNOCKOUT; RESPIRATION, ARTIFICIAL; SEPSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 22444432280     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00070.2005     Document Type: Article

References (47)

1. Adair-Kirk TL, Atkinson JJ, Broekelmann TJ, Doi M, Tryggvason K, Miner JH, Mecham RP, and Senior RM. A site on laminin alpha 5, AQARSAASKVKVSMKF, induces inflammatory cell production of matrix metalloproteinase-9 and chemotaxis. J Immunol 171: 398-406, 2003.
2. Bailey TC, Martin EL, Zhao L, and Veldhuizen RA. High oxygen concentrations predispose mouse lungs to the deleterious effects of high stretch ventilation. J Appl Physiol 94: 975-982, 2003.
3. Baker AH, Edwards DR, and Murphy G. Metalloproteinase inhibitors, biological actions and therapeutic opportunities. J Cell Sci 115: 3719-3727, 2002.
4. Bersten AD, Edibam C, Hunt T, and Moran J. Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian states. Am J Respir Crit Care Med 165: 443-448, 2002.
5. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, and Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4: 197-250, 1993.
6. Black RA. TIMP3 checks inflammation. Nat Genet 36: 934-935, 2004.
7. Bonniaud P, Kolb M, Galt T, Robertson J, Robbins C, Stampfli M, Lavery C, Margetts PJ, Roberts AB, and Gauldie J. Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol 173: 2099-2108, 2004.
8. Brew K, Dinakarpandian D, and Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477: 267-283, 2000.
9. Clowes GH Jr. Pulmonary abnormalities in sepsis. Surg Clin North Am 54: 993-1013, 1974.
10. Dauger S, Ferkdadji L, Saumon G, Vardon G, Peuchmaur M, Gaultier C, and Gallego J. Neonatal exposure to 65% oxygen durably impairs lung architecture and breathing pattern in adult mice. Chest 123: 530-538, 2003.
11. Dick CA, Singh P, Daniels M, Evansky P, Becker S, and Gilmour MI. Murine pulmonary inflammatory responses following instillation of size-1 fractionated ambient particulate matter. J Toxicol Environ Health A 66: 2193-2207, 2003.
12. Finlay GA, O'Driscoll LR, Russell KJ, D'Arcy EM, Masterson JB, FitzGerald MX, and O'Connor CM. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 156: 240-247, 1997.
13. Finlay GA, Russell KJ, McMahon KJ, D'Arcy EM, Masterson JB, FitzGerald MX, and O'Connor CM. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax 52: 502-506, 1997.
14. Foda HD, Rollo EE, Drews M, Conner C, Appelt K, Shalinsky DR, and Zucker S. Ventilator-induced lung injury upregulates and activates gelatinases and EMMPRIN: attenuation by the synthetic matrix metalloproteinase inhibitor, Prinomastat (AG3340). Am J Respir Cell Mol Biol 25: 717-724, 2001.
15. Gunja-Smith Z, Morales AR, Romanelli R, and Woessner JF Jr. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links. Am J Pathol 148: 1639-1648, 1996.
16. Haseneen NA, Vaday GG, Zucker S, and Foda HD. Mechanical stretch induces MMP-2 release and activation in lung endothelium: role of EMMPRIN. Am J Physiol Lung Cell Mol Physiol 284: L541-L547, 2003.
17. Hirano S. Migratory responses of PMN after intraperitoneal and intratracheal administration of lipopolysaccharide. Am J Physiol Lung Cell Mol Physiol 270: L836-L845, 1996.
18. Hornebeck W. Down-regulation of tissue inhibitor of matrix metalloprotease-1 (TIMP-1) in aged human skin contributes to matrix degradation and impaired cell growth and survival. Pathol Biol (Paris) 51: 569-573, 2003.
19. Hozumi A, Nishimura Y, Nishiuma T, Kotani Y, and Yokoyama M. Induction of MMP-9 in normal human bronchial epithelial cells by TNF-α via NF-KB-mediated pathway. Am J Physiol Lung Cell Mol Physiol 281: L1444-L1452, 2001.
20. Kohno M, Ishizaka A, Sawafuji M, Koh H, Hirayama Y, Ikeda E, Shiomi T, Ohashi A, Okada Y, and Kobayashi K. Hyperoxia-induced emphysematous changes in subacute phase of endotoxin-induced lung injury in rats. Am J Physiol Lung Cell Mol Physiol 287: L184-L190, 2004.
21. Kraft PJ, Haynes-Johnson DE, Patel L, Lenhart JA, Zivin RA, and Palmer SS. Fluorescence polarization assay and SDS-PAGE confirms matrilysin degrades fibronectin and collagen IV whereas gelatinase A degrades collagen IV but not fibronectin. Connect Tissue Res 42: 149-163, 2001.
22. Lambert E, Dasse E, Haye B, and Petitfrere E. TIMPs as multifacial proteins. Crit Rev Oncol Hematol 49: 187-198, 2004.
23. Leco KJ, Waterhouse P, Sanchez OH, Gowing KL, Poole AR, Wakeham A, Mak TW, and Khokha R. Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest 108: 817-829, 2001.
24. Leeman MF, Curran S, and Murray GI. New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 201: 528-534, 2003.
25. Lian X, Yan C, Yang L, Xu Y, and Du H. Lysosomal acid lipase deficiency causes respiratory inflammation and destruction in the lung. Am J Physiol Lung Cell Mol Physiol 286: L801-L807, 2004.
26. Lorino AM, Lafuma C, Atlan G, Lorino H, and Harf A. Correlation between lung structure and respiratory function in hamsters with experimental emphysema. Bull Eur Physiopath Respir 22: 371-374, 1986.
27. Lukashev ME and Werb Z. ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol 8: 437-441, 1998.
28. Martin EL, Moyer BZ, Pape MC, Starcher B, Leco KJ, and Veldhuizen RA. Negative impact of tissue inhibitor of metalloproteinase-3 null mutation on lung structure and function in response to sepsis. Am J Physiol Lung Cell Mol Physiol 285: L1222-L1232, 2003.
29. McCawley LJ and Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 13: 534-540, 2001.
30. Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, Sanchez OH, English JL, Matrisian LM, Au B, Yeh WC, and Khokha R. Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet 36: 969-977, 2004.
31. Mott JD and Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16: 558-504, 2004.
32. Ntayi C, Hornebeck W, and Bernard P. Involvement of matrix metalloproteinases (MMPs) in cutaneous melanoma progression. Pathol Biol (Paris) 52: 154-159, 2004.
33. Ohbayashi H. Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci 3: 409-421, 2002.
34. Ohnishi K, Takagi M, Kurokawa Y, Satomi S, and Konttinen YT. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab invest 78: 1077-1087, 1998.
35. Okamoto T, Akuta T, Tamura F, van D, V, and Akaike T. Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation. Biol Chem 385: 997-1006, 2004.
36. Pardo A, Barrios R, Maldonado V, Melendez J, Perez J, Ruiz V, Segura-Valdez L, Sznajder JI, and Selmari M. Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia: pathogenetic implications. Am J Pathol 153: 833-844, 1998.
37. Parks WC and Shapiro SD. Matrix metalloproteinases in lung biology. Respir Res 2: 10-19, 2001.
38. Parks WC, Wilson CL, and Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4: 617-629, 2004.
39. Petty TL. COPD in perspective. Chest 121: 116S-120S, 2002.
40. Rocco PR, Negri EM, Kurtz PM, Vasconcellos FP, Silva GH, Capelozzi VL, Romero PV, and Zin WA. Lung tissue mechanics and extracellular matrix remodeling in acute lung injury. Am J Respir Crit Care Med 164: 1067-1071, 2001.
41. Selman M, Ruiz V, Cabrera S, Segura L, Ramirez R, Barrios R, and Pardo A. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvirorment? Am J Physiol Lung Cell Mol Physiol 279: L562-L574, 2000.
42. Su X, Song Y, Jiang J, and Bai C. The role of aquaporin-1 (AQPI) expression in a murine model of lipopolysaccharide-induced acute lung injury. Respir Physiol Neurobiol 142: 1-11, 2004.
43. Tamura F, Nakagawa R, Akuta T, Okamoto S, Hamada S, Maeda H, Kawabata S, and Akaike T. Proapoptotic effect of proteolytic activation of matrix metalloproteinases by Streptococcus pyogenes thiol proteinase (Streptococcus pyrogenic exotoxin B). Infect Immun 72: 4836-4847, 2004.
44. Tokieda K, Iwamoto HS, Bachurski C, Wert SE, Hull WM, Ikeda K, and Whitsett JA. Surfactant protein-B-defichnt mice are susceptible to hyperoxic lung injury. Am J Respir Cell Mol Biol 21: 463-472, 1999.
45. Veldhuizen RA, Slutsky AS, Joseph M, and McCaig L. Effects of mechanical ventilation of isolated mouse lungs on surfactant and inflammatory cytokines. Eur Respir J 17: 488-494, 2001.
46. Von Bethmann AN, Brasch F, Nusing R, Vogt K, Volk HD, Muller KM, Wendel A, and Uhlig S. Hyperventilation induces release of cytokines from perfused mouse lung. Am J Respir Crit Care Med 157: 263-272, 1998.
47. Vu TH and Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 14: 2123-2133, 2000.